Adenosine 5'-triphosphate, uridine 5'-triphosphate, bradykinin, and lysophosphatidic acid induce different patterns of calcium responses by human articular chondrocytes

J Orthop Res. 1998 Mar;16(2):217-26. doi: 10.1002/jor.1100160209.

Abstract

Small calcium-mobilizing inflammatory mediators have been implicated in joint pathology. Here we demonstrate that bradykinin, adenosine 5'-triphosphate, uridine 5'-triphosphate, and lysophosphatidic acid raise the intracellular calcium concentration ([Ca2+]i) in human articular chondrocytes. Heterologous cross-desensitization experiments showed that the uridine 5'-triphosphate response was abolished by prior treatment with adenosine 5'-triphosphate and, conversely, that the adenosine 5'-triphosphate response was abolished by prior treatment with uridine 5'-triphosphate; this indicated competition for the same receptor site, whereas bradykinin and lysophosphatidic acid did not compete with other ligands. Pretreatment with thapsigargin abolished ligand-mediated Ca2+ responses but not vice versa; this confirmed that Ca2+ release occurred from intracellular stores. Single-cell analysis of Fura-2 acetoxymethyl ester loaded chondrocytes showed mediator-dependent patterns of oscillatory Ca2+ changes in a subset of cells when challenged with submaximal concentrations of bradykinin, adenosine 5'-triphosphate, or uridine 5'-triphosphate in the presence of extracellular Ca2+. However, no oscillatory responses were seen after a challenge with lysophosphatidic acid. Therefore, although a number of different Ca2+-mobilizing ligands activate chondrocytes, the differences that occur in the temporal patterning of Ca2+ responses may result in unique mediator-dependent changes in cellular activity.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenosine Triphosphate / pharmacology*
  • Bradykinin / pharmacology*
  • Calcium / metabolism*
  • Calcium-Binding Proteins / agonists
  • Cartilage, Articular / cytology
  • Cartilage, Articular / metabolism
  • Chondrocytes / chemistry
  • Chondrocytes / drug effects
  • Chondrocytes / metabolism*
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Fluorescent Dyes
  • Fura-2
  • Humans
  • Interleukin-1 / pharmacology
  • Ligands
  • Lysophospholipids / pharmacology*
  • Purinergic Agonists
  • Receptors, Cell Surface / agonists
  • Recombinant Proteins / pharmacology
  • Sphingosine / pharmacology
  • Staurosporine / pharmacology
  • Thapsigargin / pharmacology
  • Uridine Triphosphate / pharmacology*

Substances

  • Calcium-Binding Proteins
  • Enzyme Inhibitors
  • Fluorescent Dyes
  • Interleukin-1
  • Ligands
  • Lysophospholipids
  • Purinergic Agonists
  • Receptors, Cell Surface
  • Recombinant Proteins
  • Thapsigargin
  • Adenosine Triphosphate
  • Staurosporine
  • Sphingosine
  • Bradykinin
  • Calcium
  • Fura-2
  • Uridine Triphosphate